Related Experiment Video
Updated: Apr 15, 2026

12:01
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
11.4K
Mini review: linkage between α-Synuclein protein and cognition
Huda Saleh1, Ayeh Saleh1, Hailan Yao1
1Center for Advanced Therapeutic Strategies for Brain Disorders Roskamp Institute, Sarasota, FL 34243 USA.
Translational Neurodegeneration
|April 3, 2015
Summary
Alpha-synuclein is crucial for cognitive function. Dysfunctional alpha-synuclein contributes to neurodegenerative diseases like Parkinson's, impacting cognitive decline.
Area of Science:
- Neuroscience
- Molecular Biology
Background:
- Alpha-synuclein (α-synuclein) is a protein integral to normal brain cognitive function.
- Defects in α-synuclein are implicated in neurodegenerative disorders, notably Parkinson's disease (PD).
- Elevated α-synuclein levels in cerebrospinal fluid (CSF) correlate with accelerated cognitive decline.
Purpose of the Study:
- To review the role of α-synuclein in cognitive function within healthy brains.
- To examine the impact of α-synuclein dysfunction on cognition in diseased brains.
- To assess how soluble α-synuclein, oligomers, and extracellular transport affect neurodegeneration.
Main Methods:
- Literature review focusing on α-synuclein's role in cognition.
- Analysis of studies examining α-synuclein in both healthy and diseased brain states.
- Assessment of the impact of different α-synuclein forms and transport mechanisms on neurodegeneration.
Main Results:
- α-synuclein plays a significant, though not fully elucidated, role in normal cognitive processes.
- α-synuclein dysfunction is a key factor in the cognitive deterioration observed in neurodegenerative diseases.
- Cerebrospinal fluid α-synuclein levels serve as a biomarker for the rate of cognitive decline.
Conclusions:
- α-synuclein is vital for maintaining cognitive health.
- Understanding α-synuclein's function and dysfunction is critical for neurodegenerative disease research.
- Further investigation into α-synuclein's various forms and transport is warranted to understand its neurodegenerative impact.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Amyloid Fibrils
13.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.1K

